4EWQ | Human p38 alpha MAPK in complex with a pyridazine based inhibitor | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Grum-Tokars, V., Minasov, G., Roy, S., Schavocky, J., Winsor, J., Watterson, D.M., Anderson, W.F., CSGID, Center.for.Structural.Genomics.of.Infectious.Diseases. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.10 | ||||||||||||
ligand | ACT, BME, CL, GG5, GOL, MWL, PEG, TPO, ZN BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
|
Data retrieval |
View 4EWQ in 3D |
Visual 3D analysis of 4EWQ |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4EWQ |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |